COMMUNIQUÉS West-GlobeNewswire

-
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
04/11/2024 -
Codexis to Participate in Upcoming Healthcare Conferences
04/11/2024 -
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy
04/11/2024 -
FibroGen to Report Third Quarter 2024 Financial Results
04/11/2024 -
Sutro Biopharma Demonstrates Meaningful ADC Innovation with Five Presentations at the 15th Annual World ADC Conference
04/11/2024 -
Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
04/11/2024 -
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024
04/11/2024 -
Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024
04/11/2024 -
Foghorn Therapeutics Provides Third Quarter 2024 Financial and Corporate Update
04/11/2024 -
Mineralys Therapeutics to Announce Third Quarter 2024 Financial Results and Host Conference Call on Monday, November 11, 2024
04/11/2024 -
Amwell Makes Grants to New Employees Under Inducement Plan
04/11/2024 -
Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition
04/11/2024 -
Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024
04/11/2024 -
Supernus Announces Third Quarter 2024 Financial Results
04/11/2024 -
Inspire Medical Systems, Inc. Announces Third Quarter 2024 Financial Results and Updates 2024 Outlook
04/11/2024 -
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
04/11/2024 -
Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024
04/11/2024 -
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/11/2024 -
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/11/2024
Pages